mrctechnology.org articles

News : Barbara Saxty co-author on Nature Communications paper

Barbara Saxty has co-authored a Nature Communications paper entitled An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid.

News : MRCT-supported Research Fellow vacancy at University of Leicester

The University of Leicester is recruiting for an MRCT-supported Research Fellow

News : New drug discovery collaboration with University of Bristol launched

MRCT are collaborating with the University of Bristol to develop orally available small molecule TrkA antagonists for treatment of chronic intractable pain.

News : New cancer therapeutic antibody project launched

MRC Technology’s Therapeutic Antibody Group and The University of Aberdeen work together on project to develop therapeutic against a novel cancer target, soluble CTLA-4.

News : Aptuscan acquired by Avacta

Aptuscan, a spin out company based on research carried out at the MRC Cancer Cell Unit, has been acquired by Avacta, an AIM-listed biotechnology company.

News : MRCT to manage AICR IP

MRC Technology announced today that they have entered into an agreement with the Association for International Cancer Research (AICR) to assist in the oversight and management of intellectual property (IP) arising from AICR-funded projects.

Press Release : MRC Technology to manage intellectual property for AICR

MRC Technology to oversee and manage intellectual property arising from AICR-funded projects

News : Fuelling innovative discoveries and driving crucial research onto the market

Dave Tapolczay has spoken to Research Media's International Innovation about fuelling innovative discoveries and driving crucial research onto the market

News : Crowd sourcing in drug discovery

MRCT's Justin Bryans contributes to Nature Reviews Drug Discovery article on crowd sourcing in drug discovery

News : The art of turning ideas into products

MRCT featured in Financial Times article on university tech transfer

News : Images created using OPT scanner win Wellcome Image Award 2011

2 images created using OPT scanner win Wellcome Image Awards 2011

News : New Director of Corporate Partnerships appointed

Mike Johnson appointed as new Director of Corporate Partnerships

News : New licensing opportunity available

A licensing opp based on the finding by Leo James that antibodies can fight viruses from within the cell is now available

News : MRC scientists redefine how our immune system responds to viruses

MRC scientists redefine how our immune system responds to viruses

News : Scientists ‘give botox a facelift’ to improve use for Parkinson’s

Scientists ‘give botox a facelift’ to improve use for Parkinson’s

Press Release : 1st patient treated with BAN2401

First Alzheimer’s patient treated with BAN2401, a novel antibody targeting the neurotoxin believed to cause Alzheimer’s disease

News : MRC People Exchange Programme

MRC offers experienced researchers funding to collaborate with industry colleagues

Press Release : MRC Technology enters into an exclusive license agreement With Genentech

MRC Technology and Genentech enter into agreement for series of small molecule drug candidates. The first such programme to come out of MRC Technology.

Press Release : “Skills Swap” to exploit expertise for patient benefit

Cancer Research Technology and MRC Technology to ‘swap’ medical discoveries to accelerate the translation of early scientific research into patient benefit.

Press Release : AstraZeneca and MRC Technology form strategic alliance in discovery research, utilising shared compound libraries

AstraZeneca share 100,000 compounds with MRC Technology